CNS Pharmaceuticals, Inc.
USD3.98
-0.17 (-4.14%)
CEO
Rami Levin
IPO Date
2019-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.90
Prev. Close
$4.15
Day Low
$3.90
Day High
$4.20
52W Low
$1.90
52W High
$12.36
Market Cap
$0.00B
Volume
0.02M
| 9,500 |
| $0.00 |
| 4 Mar 2026 | Faulkner Eric | officer | Disposed | 0 | $0.00 |
| 4 Mar 2026 | O'Loughlin Steve | Chief Financial Officer | A-Award | Acquired | 9,500 | $0.00 |
| 4 Mar 2026 | O'Loughlin Steve | officer | Disposed | 0 | $0.00 |
| 2 Jan 2026 | Levin Rami | director, officer: CEO and President | A-Award | Acquired | 19,000 | $0.00 |
| 2 Jan 2026 | Levin Rami | director, officer: CEO and President | Disposed | 0 | $0.00 |
| 19 Nov 2025 | Keyes Jeffry R. | director | A-Award | Acquired | 1,517 | $12.48 |
| 19 Nov 2025 | Cockroft Bettina M. | director | A-Award | Acquired | 1,517 | $12.48 |
| 19 Nov 2025 | Climaco John M | director, officer: Chief Executive Officer | A-Award | Acquired | 9,761 | $30.00 |